Document Detail


Long-term treatment in children with hypopituitarism: pubertal development and final height.
MedLine Citation:
PMID:  9485176     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Auxological data, pubertal development and final height were analyzed in 25 patients with growth hormone (GH) deficiency who were treated only with pituitary GH in 3 doses/week. 15 patients had a spontaneous onset of puberty and in 10 puberty was induced. The duration of therapy was 7.5 years, the dosage was about 11 U/m2/week and was not changed during puberty. 80% of the patients with induced puberty, but only 33% of the children with spontaneous puberty reached final heights within the 2 SD range. Final height was correlated with height at the start of treatment only in patients with spontaneous puberty, which shows the necessity of early treatment initiation in this group. The lack of this correlation in patients with induced puberty might be attributed to gonadotropin deficiency. Height at the onset of puberty was related to final height only in the group with gonadotropin deficiency. A prediction model for calculation of the first year height velocity which was derived from present treatment procedures showed a too favorable prediction for our patients. The reasons for the insufficient final results may be due to impure GH preparations, suboptimal dosage, low frequency of injections and late onset of therapy.
Authors:
R Birnbacher; S Riedl; H Frisch
Related Documents :
19568466 - Cyst ablation using a mixture of n-butyl cyanoacrylate and iodized oil in patients with...
9389996 - Evidence supporting surgery as treatment of choice for acromegaly.
9098666 - Octreotide long-acting release (lar). a review of its pharmacological properties and th...
10570446 - Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropan...
21822596 - Laparoscopic versus conventional open surgery for immune function in patients with colo...
1992546 - Total gastrectomy for gastric cancer in the elderly.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Hormone research     Volume:  49     ISSN:  0301-0163     ISO Abbreviation:  Horm. Res.     Publication Date:  1998  
Date Detail:
Created Date:  1998-04-03     Completed Date:  1998-04-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0366126     Medline TA:  Horm Res     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  80-5     Citation Subset:  IM    
Affiliation:
Pediatric Department, Endocrinology, University Hospital Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Body Height / drug effects*
Child
Female
Growth Hormone / blood,  therapeutic use*
Humans
Hypopituitarism / drug therapy*,  physiopathology
Male
Puberty / drug effects*
Thyroxine / blood
Chemical
Reg. No./Substance:
7488-70-2/Thyroxine; 9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum insulin-like growth factors I and II are not affected by undernutrition in children with nonor...
Next Document:  Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in peri...